跳至主要内容
临床试验/NCT03391609
NCT03391609已完成2 期

Peri-operative Dexmedetomidine Infusion in Mild Pre-eclamptic Patients Undergoing Elective Cesarean Section Under General Anesthesia

Assiut University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年6月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
30
试验地点
1
主要终点
postoperative analgesia

研究概览

简要总结

The purpose of this study is to investigate the effects of dexmedetomidine infusion on the stress response to intubation, postoperative analgesia, and renal functions (urinary output [UOP], creatinine and glomerular filtration rate [GFR]) in preeclamptic patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

double-blinding

入排标准

年龄范围
19 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women
  • have mild preeclampsia ( Pre-eclamptic patients will be defined as having hypertension [systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP)≥90 mmHg] accompanied by proteinuria first detected after 20 weeks of gestation).
  • Proteinuria is defined as at least 300 mg protein in 24 h urine collection [or ≥1+ dipstick (30 mg/dl) in a single urine sample] ).
  • American Society of Anesthesiologists (ASA) physical status of II or III.
  • age between 19 and 40 years

排除标准

  • patient refusal to consent (obsolete).
  • pre-existing neurological disease or psychic patients.
  • history of cardiac and respiratory system failure.
  • co-existing significant renal or liver disease.

研究组 & 干预措施

control group

Placebo Comparator

Caesarian section will be performed under standard general anesthesia plus pre and intra operative saline infusion (placebo) in the same rate as dexmedetomedine starting 15 minutes before induction of general anesthesia and continue till peritoneum closure.

干预措施: placebo infusion (Drug)

Dex. group

Active Comparator

Caesarian section will be performed under standard general anesthesia plus pre and intra operative Dexmedetomidine infusion in a dose of 0.5mic/kg/hour starting 15 minutes before induction of general anesthesia and continue till peritoneum closure.

干预措施: Dexmedetomidine infusion (Drug)

结局指标

主要结局

postoperative analgesia

时间窗: 24 hours postoperatively

through VAS score readings

次要结局

  • untoward events(24 hours postoperatively)
  • renal function(24 hours postoperatively)
  • stress response(24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmad Mohammad Abd El-Rahman

lecturer

Assiut University

研究点 (1)

Loading locations...

相似试验